Physician

Rishi Kad, M.D.

According to 2025 Medicare claims, Rishi Kad, M.D. (NPI: 1386880227) practices internal medicine in the Weirton-Steubenville, WV-OH market, with the plurality of this provider's patient population coming from Hancock, WV. This provider's primary affiliated billing organization is WMC PHYSICIAN PRACTICES LLC (NPI: 1518303288; TIN: 461883875) and primary practice location at 26062-0538.

Kad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 873 traditional Medicare patients, billed 2,645 HCPCS/CPT codes, and received $136,831 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,785 prescription claims across 420 beneficiaries totaling $354,149 in drug costs, led by Eliquis (Apixaban). DME data shows 12 claims. Open Payments data shows 89 records totaling $1,878. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $40,710 to $136,831. Similarly, Part D prescription costs have risen steadily, from $49,525 to $354,149. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	272	438	$40,710
2016	275	488	$43,211
2017	229	389	$33,699
2018	279	499	$43,139
2019	471	848	$47,727
2020	400	674	$27,309
2021	571	1,041	$45,090
2022	1,191	2,675	$104,722
2023	1,191	3,129	$153,510
2024	873	2,645	$136,831

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	166	1,205	$49,525
2016	151	697	$34,512
2017	130	537	$31,290
2018	163	741	$63,987
2019	137	636	$67,404
2020	21	134	$14,935
2021	53	305	$37,089
2022	297	1,544	$179,300
2023	399	2,439	$378,831
2024	420	2,785	$354,149

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$30,851
2024	N/R	12	$869

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	206	314	$83
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	125	277	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	220	292	$56
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	304	339	$50
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	428	517	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	204	9,060	$175,564
Xarelto	Rivaroxaban	42	1,887	$34,758
Repatha Sureclick	Evolocumab	49	1,408	$26,692
Entresto	Sacubitril/Valsartan	20	900	$20,807
Jardiance	Empagliflozin	29	920	$18,172

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	12	$869

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	89	$1,878	Lexicon Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rishi Kad, M.D.?

Tedicare shows public-source Medicare data for Rishi Kad, M.D. (NPI 1386880227), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rishi Kad, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rishi Kad, M.D.?

Rishi Kad, M.D. is linked to WMC PHYSICIAN PRACTICES LLC (billing NPI 1518303288) in the available physician profile data.

Does Rishi Kad, M.D. have Open Payments data?

Rishi Kad, M.D. has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.